Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
Neha Parikh,1 William G Kramer,2 Varun Khurana,1 Christina Cognata Smith,1 Santosh Vetticaden,1 1INSYS Therapeutics, Inc., Chandler, AZ, USA; 2Kramer Consulting LLC, North Potomac, MD, USA Background: Dronabinol, a pharmaceutical Δ-9-tetrahydrocannabinol, was originally developed as an ora...
Enregistré dans:
Auteurs principaux: | Parikh N, Kramer WG, Khurana V, Cognata Smith C, Vetticaden S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4aa8035f493d4609a16cbffdcaf6e2b2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
par: Oh DA, et autres
Publié: (2017) -
Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS
par: Badowski ME, et autres
Publié: (2016) -
Cannabinoids—Characteristics and Potential for Use in Food Production
par: Joanna Kanabus, et autres
Publié: (2021) -
A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers
par: Karpecki PM, et autres
Publié: (2019) -
Separating the true from the false: A rapid HPTLC-ESI-MS method for the determination of cannabinoids in different oils
par: Theresa Schmidt, et autres
Publié: (2021)